export const searchResult = {
  search: true,
  loader: false,
  success: true,
  data: [
    {
      score: 4.00089,
      protocolNumber: "1",
      AiDocId: "9f91e2fc-f820-453b-bde8-43c6f2db4608",
      indication: "1",
      sponsor: "",
      sourceDocument: "Protocol-2013-05-29-VER-V1.0-000001.pdf",
      uploadDate: "20201210103930",
      followed: false,
      rows: [],
      rowsLoading: true,
    },
    {
      score: 2.8974314,
      protocolNumber: "a",
      AiDocId: "12f73486-676a-47fd-8830-bd8f6e98d89f",
      protocolDescription:
        "Protocol Title: Insert the full title from the title page.",
      indication: "a",
      sponsor: "",
      sourceDocument: "0055 core protocol_Feb 10.docx",
      uploadDate: "20201210111629",
      followed: false,
      rows: [],
      rowsLoading: true,
    },
  ],
};
export const NosearchResult = {
  search: true,
  loader: false,
  success: true,
  data: [],
};
export const indication = {
  success: true,
  sectionContent: [
    {
      title: "ind1",
      id: 1,
    },
    {
      title: "ABCC6 deficiency",
      id: 2,
    },
    {
      title: "ADHD",
      id: 3,
    },
    {
      title: "AIDS",
      id: 4,
    },
    {
      title: "Achondroplasia disorder",
      id: 5,
    },
    {
      title: "Acute lymphocytic leukemia",
      id: 6,
    },
    {
      title: "Coccidioidomycosis",
      id: 7,
    },
    {
      title: "Cough",
      id: 8,
    },
    {
      title: "Dry eye",
      id: 9,
    },
    {
      title: "Female sexual dysfunction",
      id: 10,
    },
  ],
};

export const sponser = {
  success: true,
  sectionContent: [
    {
      title: "sponsor1",
      id: 1,
    },
    {
      title: "Astellas Pharma Inc",
      id: 2,
    },
    {
      title: "NVT AG",
      id: 3,
    },
    {
      title: "Cyberonics, Inc.",
      id: 4,
    },
    {
      title: "CliRes",
      id: 5,
    },
    {
      title: "Pfizer Consumer Health",
      id: 6,
    },
    {
      title: "Hospira",
      id: 7,
    },
  ],
};

export const phase = {
  success: true,
  sectionContent: [
    {
      id: 1,
      title: "Phase 0",
    },
    {
      id: 2,
      title: "Phase 1a",
    },
    {
      id: 3,
      title: "Phase 1b",
    },
    {
      id: 4,
      title: "Phase 2a",
    },
    {
      id: 5,
      title: "Phase 2b",
    },
    {
      id: 6,
      title: "Phase 3a",
    },
    {
      id: 7,
      title: "Phase 3b",
    },
    {
      id: 8,
      title: "Phase 1b/2a",
    },
    {
      id: 9,
      title: "Phase 2b/3a",
    },
    {
      id: 10,
      title: "Phase 1b/2",
    },
    {
      id: 11,
      title: "Phase 2b/3",
    },
    {
      id: 12,
      title: "Phase 3b/4",
    },
  ],
};

export const searchCardData = {
  protocolNumber: "EMR 200095-004",
  AiDocId: "59d90147-ab52-40f4-801c-2c9f4f752f27",
  protocolDescription: "Paragraph",
  indication: "ABCC6 deficiency and new Disease for testing",
  phase: "II",
  sponsor: "Numerics word , Countries, Country,Numerics word , Countries, Country ",
  molecule: "Global Biostatistics Global Biostatistics",
  approval_date: "20130118",
  projectId:"UXA27595UXA27595UXA27595UXA27595",
  uploadDate: "20210118133407",
  followed: false,
  rows: [
    {
      id: "cefc801f-3a56-44e3-a3af-174db201c824",
      userId: "1072234",
      fileName: "D361BC00001 Protocol-2020-03-03-VER-1.0.pdf",
      documentFilePath:
        "\\\\quintiles.net\\enterprise\\Services\\protdigtest\\pilot_iqvxml\\cefc801f-3a56-44e3-a3af-174db201c824\\D361BC00001 Protocol-2020-03-03-VER-1.0.pdf",
      protocol: "PD-SDS-PROT-S2",
      projectId: "",
      sponsor: "3D Medical",
      indication: "Acne",
      moleculeDevice: "SDS-2",
      amendment: "N",
      isProcessing: false,
      percentComplete: "100",
      compareStatus: null,
      iqvXmlPathProc: null,
      iqvXmlPathComp: null,
      shortTitle:
        "Capivasertib + Abiraterone as Treatment for Patients with Metastatic Hormone-Sensitive Prostate Cancer Characterised by PTEN deficiency.",
      versionNumber: "1.1",
      documentStatus: "draft",
      draftVersion: "1.11",
      errorCode: 1,
      errorReason:
        "Digitizer2Standard template file does not exist 'D:\\Projects\\IQVDocumentManager\\Code\\Release\\D2_cpt1.docx.iqv.xml.zip'",
      status: "PROCESS_COMPLETED",
      phase: "III",
      digitizedConfidenceInterval: null,
      completenessOfDigitization: null,
      protocolTitle:
        "A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Abiraterone Versus Placebo + Abiraterone as Treatment for Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Characterised by PTEN deficiency (CAPItello-281)",
      studyStatus: null,
      sourceSystem: null,
      environment: null,
      uploadDate: "2021-05-28T09:50:51.270000",
      timeCreated: "2021-05-28T09:50:51.270000",
      lastUpdated: "2021-05-28T10:22:12.900000",
      userCreated: null,
      userUpdated: null,
      approvalDate: "2020-03-03T00:00:00",
      isActive: true,
      nctId: null,
    },
  ],
  rowsLoading: false,
  isActive: 1,
  expanded: true,
  id: "EMR 200095-004",
};
export const searchCardData2 = {
  protocolNumber: "EMR 200095-004",
  AiDocId: "59d90147-ab52-40f4-801c-2c9f4f752f27",
  protocolDescription: "Paragraph",
  indication: "ABCC6 deficiency",
  phase: "II",
  sponsor: "AstraZeneca",
  molecule: "Global",
  approval_date: null,
  projectId:"UXA27595",
  uploadDate: null,
  followed: false,
  rows: [
    {
      id: "cefc801f-3a56-44e3-a3af-174db201c824",
      userId: "1072234",
      fileName: "D361BC00001 Protocol-2020-03-03-VER-1.0.pdf",
      documentFilePath:
        "\\\\quintiles.net\\enterprise\\Services\\protdigtest\\pilot_iqvxml\\cefc801f-3a56-44e3-a3af-174db201c824\\D361BC00001 Protocol-2020-03-03-VER-1.0.pdf",
      protocol: "PD-SDS-PROT-S2",
      projectId: "",
      sponsor: "3D Medical",
      indication: "Acne",
      moleculeDevice: "SDS-2",
      amendment: "N",
      isProcessing: false,
      percentComplete: "100",
      compareStatus: null,
      iqvXmlPathProc: null,
      iqvXmlPathComp: null,
      shortTitle:
        "Capivasertib + Abiraterone as Treatment for Patients with Metastatic Hormone-Sensitive Prostate Cancer Characterised by PTEN deficiency.",
      versionNumber: "1.1",
      documentStatus: "draft",
      draftVersion: "1.11",
      errorCode: 1,
      errorReason:
        "Digitizer2Standard template file does not exist 'D:\\Projects\\IQVDocumentManager\\Code\\Release\\D2_cpt1.docx.iqv.xml.zip'",
      status: "PROCESS_COMPLETED",
      phase: "III",
      digitizedConfidenceInterval: null,
      completenessOfDigitization: null,
      protocolTitle:
        "A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Abiraterone Versus Placebo + Abiraterone as Treatment for Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Characterised by PTEN deficiency (CAPItello-281)",
      studyStatus: null,
      sourceSystem: null,
      environment: null,
      uploadDate: "2021-05-28T09:50:51.270000",
      timeCreated: "2021-05-28T09:50:51.270000",
      lastUpdated: "2021-05-28T10:22:12.900000",
      userCreated: null,
      userUpdated: null,
      approvalDate: "2020-03-03T00:00:00",
      isActive: true,
      nctId: null,
    },
  ],
  rowsLoading: false,
  isActive: 1,
  expanded: true,
  id: "EMR 200095-004",
};

export const paramsLocation = {
  search:
    "?key=advanced&sponsor=3-D%20Pharmaceuticals&indication=ABCC6%20deficiency&phase=Phase%200&documentStatus=final&toc=Protocol%20Summary&dateType=approval_date&dateSection=12&dateFrom=20200416&dateTo=20210416",
};
